Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exicure, Inc. - Common Stock (NQ:XCUR)

7.030 -0.240 (-3.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,898
Open 7.270
Bid (Size) 6.310 (1)
Ask (Size) 7.250 (3)
Prev. Close 7.270
Today's Range 6.740 - 7.464
52wk Range 1.440 - 36.00
Shares Outstanding 88,108,543
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks have an unusual volume on Thursday?
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
-53.7%
-53.7%
1 Month
-19.8%
-19.8%
3 Month
-40.1%
-40.1%
6 Month
-11.0%
-11.0%
1 Year
+330.9%
+330.9%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Exicure, Inc. Reports First Quarter 2025 Financial Results
From Exicure, Inc.
Via Business Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
From Exicure, Inc.
Via Business Wire
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
From Exicure, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
From Exicure, Inc.
Via Business Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)
From Exicure, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Exicure, Inc. Reports Full Year 2024 Financial Results
From Exicure, Inc.
Via Business Wire
Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia
From Exicure, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Exicure Stock Soars Over 25% On Acquisition Of GPCR Therapeutics’ U.S. Unit: Retail Chatter Spikes
Via Stocktwits
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
From Exicure, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
From Exicure, Inc.
Via Business Wire
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
From Exicure, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Exicure, Inc. - Common Stock publicly traded?
Yes, Exicure, Inc. - Common Stock is publicly traded.
What exchange does Exicure, Inc. - Common Stock trade on?
Exicure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exicure, Inc. - Common Stock?
The ticker symbol for Exicure, Inc. - Common Stock is XCUR on the Nasdaq Stock Market
What is the current price of Exicure, Inc. - Common Stock?
The current price of Exicure, Inc. - Common Stock is 7.030
When was Exicure, Inc. - Common Stock last traded?
The last trade of Exicure, Inc. - Common Stock was at 07/14/25 04:00 PM ET
What is the market capitalization of Exicure, Inc. - Common Stock?
The market capitalization of Exicure, Inc. - Common Stock is 619.40M
How many shares of Exicure, Inc. - Common Stock are outstanding?
Exicure, Inc. - Common Stock has 619M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.